Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protease associated domain containing 1 pseudogene 1 (PRADC1P1) is classified as a human pseudogene according to the HUGO Gene Nomenclature Committee (HGNC) and other gene databases[1][3][5][7]. Pseudogenes are DNA sequences that resemble protein-coding genes but are typically non-functional due to mutations that prevent the expression of a functional protein[4]. PRADC1P1 does not encode a protein and is not known to have a direct biological or therapeutic function. While some pseudogenes may have regulatory roles, such as through their RNA transcripts, there is no evidence supporting a biological function or disease association for PRADC1P1 specifically. It is not considered a therapeutic target, nor does it have known interacting drugs, biomarker relevance, or notable safety concerns[4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protease associated domain containing 1 pseudogene 1 (PRADC1P1).